MABWELL-B 02493Hong Kong Stock Exchange

20.4000.10%( +0.020 )
Closed: Oct 12 · Delayed · Hong Kong Stock Exchange
MABWELL-B (02493) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
Mabwell (Shanghai) Bioscience Co., Ltd.
Market
HKEX Main Board
Listing Date
2026-04-28
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100007HT5
Southbound Connect
Shanghai · Shenzhen

Related Securities

Industry

Innovative Drugs & Biologics 1.38%
124 stocks in this industry
Down 78 Up 36
Industry RankingsValue (HKD)Rank
Revenue (Last FY)772.34M61/112
Net Profit (Last FY)-1.14B118/125
ROE (Last FY)-277.34%117/117

Change is the 2026-10-12 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
唐春山 Executive Director
刘大涛 Executive Director
武海 Executive Director
华俊 Executive Director
桂勋 Executive Director
秦正余 Independent Non-Executive Director
周睿 Independent Non-Executive Director
李凡 Independent Non-Executive Director
王芳 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-18.

About this page

This page shows MABWELL-B (02493) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.